|
EML4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.10782519111308E-15 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.3988810110277E-14 |
| Normal-vs-Stage2 |
6.248500E-04 |
| Normal-vs-Stage3 |
1.15389999777449E-08 |
| Normal-vs-Stage4 |
5.55289999981667E-07 |
| Stage1-vs-Stage2 |
6.035800E-01 |
| Stage1-vs-Stage3 |
4.462600E-01 |
| Stage1-vs-Stage4 |
8.369600E-02 |
| Stage2-vs-Stage3 |
9.646200E-01 |
| Stage2-vs-Stage4 |
6.239600E-01 |
| Stage3-vs-Stage4 |
4.209600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.10782519111308E-15 |
| Normal-vs-AfricanAmerican |
5.243900E-04 |
| Normal-vs-Asian |
2.39540000002147E-06 |
| Caucasian-vs-AfricanAmerican |
2.161800E-01 |
| Caucasian-vs-Asian |
6.216100E-02 |
| AfricanAmerican-vs-Asian |
1.470160E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.02179947730963E-10 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
4.01669999999799E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.521800E-02 |
| Normal-vs-Age(41-60Yrs) |
1.71551661765079E-12 |
| Normal-vs-Age(61-80Yrs) |
2.5365265443611E-12 |
| Normal-vs-Age(81-100Yrs) |
2.219700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.205180E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.978200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.986800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.267200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.171200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.782000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.182500E-03 |
| Normal-vs-Grade 2 |
1.70841119029319E-12 |
| Normal-vs-Grade 3 |
2.43804976207684E-13 |
| Normal-vs-Grade 4 |
6.986900E-04 |
| Grade 1-vs-Grade 2 |
7.633000E-01 |
| Grade 1-vs-Grade 3 |
4.985600E-01 |
| Grade 1-vs-Grade 4 |
7.312200E-02 |
| Grade 2-vs-Grade 3 |
4.347800E-01 |
| Grade 2-vs-Grade 4 |
3.004000E-03 |
| Grade 3-vs-Grade 4 |
1.455840E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
2.33499999999776E-05 |
| ccA subtype-vs-ccB subtype |
1.19599999903741E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.64346314335262E-12 |
| Normal-vs-N1 |
7.467600E-02 |
| N0-vs-N1 |
4.376400E-01 |
|
|
